Referencia número: HY-17538

Copy Link Print Information

ZLN005

51 Cited Publications

Revisión del cliente

Based on 51 publication(s) in Google Scholar

ZLN005 is a potent activator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α).

Para uso exclusivo en investigación. No vendemos a pacientes.

Pureza: 99.05%
No. CAS: 49671-76-3
Fòrmula: C₁₇H₁₈N₂
Peso molecular:250.34

Almacenamiento:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year

ZLN005 Chemical Structure

No. CAS: 49671-76-3

Tamaño

Precio

Stock

Cantidad

Amount: USD 0.00

* Seleccione Cantidad antes de agregar artículos.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Actividad biológica
- Descripciòn
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Publications (51)
Solvente y solubilidad
- In Vitro
- In Vivo
Pureza y Documentación
Referencias
Help & FAQs
Classifications
Bioz

Actividad biológica

Descripciòn

ZLN005 is a potent activator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)^[1].

IC₅₀ & Target

Peroxisome proliferator-activated receptor-γ coactivator-1α^[1]

In Vitro

ZLN005 (2.5-20 μM; 24 hours ) activates AMPK in a dose-dependent manner^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

L6 myotubes
Concentration:

2.5, 5, 10, 20 μM
Incubation Time:

24 hours
Result:

Dose-dependent activation of AMPK.

In Vivo

ZLN005 (15 mg/kg; p.o.; per day for 4 weeks) decreases random blood glucose and fasting blood glucose levels over 4 weeks compared with lean mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Eight-week-old db/db mice^[1]
Dosage:

15 mg/kg
Administration:

Oral administration; per day for 4 weeks
Result:

Random blood glucose and fasting blood glucose levels decreased significantly over 4 weeks compared with lean mice.

Chemical Information

No. CAS 49671-76-3
Appearance Solid
Peso molecular 250.34
Fòrmula C₁₇H₁₈N₂
Color Off-white to light brown
SMILES

CC(C1=CC=C(C2=NC3=CC=CC=C3N2)C=C1)(C)C
Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Publications (51)

All Histological Imaging/StainingWB

Sort by:

Journal Impact Factor

Metabolism

Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition. [Abstract]

2023 Aug:145:155592. PMID: 37230215
Redox Biol

PGC-1α-mediated mitochondrial homeostasis imbalance aggravated gingival lesions of diabetic periodontitis by disrupting ECM remodeling of human gingival fibroblast. [Abstract]

2025 Aug 22:86:103829. PMID: 40865270

ZLN005 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Aug 22:86:103829. [Abstract]

The intraoral photographs of rats in diabetic periodontitis group (DP) and ZLN005 (0.1 mg/mL, 30 μL) intervened diabetic periodontitis group (DP + ZLN005).

ZLN005 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Aug 22:86:103829. [Abstract]

Vernier caliper was used to measure the periodontal probing depth in both groups, and we found that ZLN005 (0.1 mg/mL, 30 μL) could largely reduce the periodontal probing depth (0.82 ± 0.08 mm vs 0.54 ± 0.07 mm), and the difference was statistically significant.

ZLN005 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Aug 22:86:103829. [Abstract]

TEM images revealed that after the intervention of ZLN005 (0.1 mg/mL, 30 μL), the morphology and structure of mitochondria in the rat gingival tissues were basically restored to normal, which indicating that mitochondria homeostatic imbalance was ameliorated in DP + ZLN005 group.

ZLN005 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Aug 22:86:103829. [Abstract]

HE and Masson staining verified that the less infiltrating inflammatory cells and the less fractured collagen fibers were found in the gingival connective tissues of DP + ZLN005 (0.1 mg/mL, 30 μL) group.

ZLN005 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2025 Aug 22:86:103829. [Abstract]

Western blot demonstrated that there were decreased protein levels of MMP1 and MMP3, whereas increased levels of TIMP1 and COL1A1 in DP + ZLN005 group, which suggested the disturbance of ECM remodeling in gingival connective tissues of DP rats was effectively improved.
Mol Cell

CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. [Abstract]

2023 Dec 7;83(23):4370-4385.e9. PMID: 38016475
Genes Dis

PGC-1α promotes mitochondrial respiration and biogenesis during the differentiation of hiPSCs into cardiomyocytes. [Abstract]

2020 Dec 23;8(6):891-906. PMID: 34522716
Adv Sci (Weinh)

PGC1α-Inducing Senomorphic Nanotherapeutics Functionalized with NKG2D-Overexpressing Cell Membranes for Intervertebral Disc Degeneration. [Abstract]

2024 Jun;11(22):e2400749. PMID: 38554394
J Hazard Mater

Daucosterol confers protection against T-2 toxin induced blood-brain barrier toxicity through the PGC-1α-mediated defensive response in vitro and in vivo. [Abstract]

2023 Oct 5:459:132262. PMID: 37604032
Cell Death Discov

Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson's disease through inhibition of H3K4me3 demethylation. [Abstract]

2025 Jul 29;11(1):351. PMID: 40730642
Cell Death Discov

DNMBP-AS1/hsa-miR-30a-5p/PGC1α axis suppresses tumor progression of colorectal cancer by inhibiting PKM2-mediated Warburg effect and enhance anti-PD-1 therapy efficacy. [Abstract]

2025 Jul 2;11(1):299. PMID: 40603870
J Transl Med

An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway. [Abstract]

2023 Jul 20;21(1):486. PMID: 37475042
Free Radic Biol Med

Nanoplastic exposure induces mitochondrial dysfunction-driven inflammation and senescence in renal tubular epithelial cells. [Abstract]

2026 May 19:253:18-35. PMID: 42162843
J Agric Food Chem

Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling. [Abstract]

2024 Jul 17;72(28):15740-15754. PMID: 38970822
CNS Neurosci Ther

Alpha-Asarone modulates kynurenine disposal in muscle and mediates resilience to stress-induced depression via PGC-1α induction. [Abstract]

2023 Mar;29(3):941-956. PMID: 36575869
Cell Mol Life Sci

PGC1α regulates the mitochondrial metabolism response to cyclic stretch, which inhibits neointimal hyperplasia. [Abstract]

2025 Aug 8;82(1):303. PMID: 40779200
Life Sci

Oxytocin ameliorates cardiac hypertrophy by inhibiting mitochondrial dysfunction and pyroptosis via AMPK/PGC-1α /TFAM pathway. [Abstract]

2026 Apr 15:391:124281. PMID: 41722768
Int Endod J

Sympathetic nerves inhibit dental pulp stem cell differentiation and tertiary dentine formation via α1B-adrenergic receptor. [Abstract]

2025 Jul 14. PMID: 40660609
Food Funct

Cynarin alleviates apical periodontitis by inhibiting macrophage M1 polarization via the PGC1α/ROS signaling axis. [Abstract]

2026 Jun 22;17(12):5378-5393. PMID: 42132631
Cells

ZLN005, a PGC-1α Activator, Protects the Liver against Ischemia-Reperfusion Injury and the Progression of Hepatic Metastases. [Abstract]

2024 Aug 29;13(17):1448. PMID: 39273020
Pharmaceuticals (Basel)

ZLN005 Alleviates In Vivo and In Vitro Renal Fibrosis via PGC-1α-Mediated Mitochondrial Homeostasis. [Abstract]

2022 Mar 31;15(4):434. PMID: 35455432
Int Immunopharmacol

Diosmetin ameliorates psoriasis-associated inflammation and keratinocyte hyperproliferation by modulation of PGC-1α / YAP signaling pathway. [Abstract]

2024 May 14:134:112248. PMID: 38749332
Int J Mol Sci

Berberine Protects against NEFA-Induced Impairment of Mitochondrial Respiratory Chain Function and Insulin Signaling in Bovine Hepatocytes. [Abstract]

2018 Jun 6;19(6). pii: E1691. PMID: 29882814

ZLN005 purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2018 Jun 6;19(6). pii: E1691. [Abstract]

The protein expression levels of COI~IV and the phosphorylation levels of Akt and GSK3β in the NEFA+ZLN005 group are significantly higher than in the non-esterified fatty acid (NEFA) group.
Mol Neurobiol

ZLN005 Alleviates the Dopaminergic Degeneration via PGC-1α-Mediated Mitochondrial Homeostasis in Parkinson's Disease. [Abstract]

2025 Dec 16;63(1):303. PMID: 41400900
Neurochem Int

Spinal p38 MAPK/PGC-1α/SIRT3 signaling pathway mediates remifentanil-induced hyperalgesia in rats via ROS release and NR2B activation. [Abstract]

2025 Sep 26:106061. PMID: 41016638
Front Pharmacol

5-HT1F Receptor Agonist Ameliorates Mechanical Allodynia in Neuropathic Pain via Induction of Mitochondrial Biogenesis and Suppression of Neuroinflammation. [Abstract]

2022 Mar 3;13:834570. PMID: 35308244
Biochim Biophys Acta Mol Basis Dis

PGC-1α role in rescuing ferroptosis in cerebral ischemia/reperfusion injury through promoting mitochondrial biogenesis and UCP2 expression. [Abstract]

2025 Apr 26;1871(6):167874. PMID: 40294850
Biochim Biophys Acta Mol Basis Dis

Cholesterol 25-hydroxylase prevents type 2 diabetes mellitus induced cardiomyopathy by alleviating cardiac lipotoxicity. [Abstract]

2024 Apr 6;1870(5):167158. PMID: 38588780
Mol Med Rep

p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis. [Abstract]

2020 Jul;22(1):155-164. PMID: 32377739
Cell Calcium

Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescence. [Abstract]

2025 Aug 26:132:103071. PMID: 40902499
Neuropharmacology

ZLN005, a PGC-1α agonist, delays photoreceptor degeneration by enhancing mitochondrial biogenesis in a murine model of retinitis pigmentosa. [Abstract]

2025 Feb 12:269:110361. PMID: 39952351
J Dairy Sci

Sirtuin 3 relieves inflammatory responses elicited by lipopolysaccharide via the PGC1α-NFκB pathway in bovine mammary epithelial cells. [Abstract]

2023 Feb;106(2):1315-1329. PMID: 36494223
J Inflamm Res

ZLN005 Reduces Neuroinflammation and Improves Mitochondrial Function in Mice with Perioperative Neurocognitive Disorders. [Abstract]

2024 Nov 4:17:8135-8146. PMID: 39525311
Environ Toxicol Pharmacol

PM2.5 induces cardiac defects via AHR-SIRT1-PGC-1α mediated mitochondrial damage. [Abstract]

2024 Mar:106:104393. PMID: 38367920
Brain Res Bull

Activation of spinal PGC-1α regulates microglial polarization through a feedback loop between ROS-mediated mitochondrial dysfunction and the NLRP3 inflammasome in neuropathic pain. [Abstract]

2025 Apr 30:111365. PMID: 40316183
BMC Complement Med Ther

Identification of volatile active components in Acori Tatarinowii Rhizome essential oil from different regions in China by C6 glioma cells. [Abstract]

2020 Aug 17;20(1):255. PMID: 32807141
Front Biosci (Landmark Ed)

Telomerase Reverse Transcriptase Regulates Intracellular Ca2+ Homeostasis and Mitochondrial Function via the p53/PGC-1α Pathway in HL-1 Cells. [Abstract]

2024 Jul 23;29(7):263. PMID: 39082363
Neurotox Res

PEG300 Protects Mitochondrial Function By Upregulating PGC-1α to Delay Central Nervous System Oxygen Toxicity in Mice. [Abstract]

2024 Jun 17;42(4):30. PMID: 38884699
J Funct Foods

2023 Nov, 110, 105825.
Cytokine

The Src1-PGC1α-AP1 complex-dependent secretion of substance P induces inflammation and apoptosis in encephalomyocarditis virus-infected mice. [Abstract]

2023 May:165:156186. PMID: 36989655

ZLN005 purchased from MedChemExpress. Usage Cited in: Cytokine. 2023 May:165:156186. [Abstract]

ZLN005 (10, 20 μM; 6 h) increases the protein levels of TAC1, Bax, Bim, cleaved Caspase 1 (C-CAP1), and cleaved Caspase 9 (C-CAP9) in a dose-dependent manner in HL-1 cells.
Toxicol Appl Pharmacol

BPDE and B[a]P induce mitochondrial compromise by ROS-mediated suppression of the SIRT1/TERT/PGC-1α pathway in spermatogenic cells both in vitro and in vivo. [Abstract]

2019 Aug 1:376:17-37. PMID: 31085209
Reprod Toxicol

Melatonin attenuates di-(2-ethylhexyl) phthalate-induced apoptosis of human granulosa cells by inhibiting mitochondrial fission. [Abstract]

2022 Oct:113:18-29. PMID: 35952901
Cardiovasc Toxicol

Quercetin Antagonizes Doxorubicin-Induced Cardiotoxicity via HO-1/PGC-1α-ALOX5 Axis: Arachidonic Acid Metabolism-Ferroptosis Crosstalk as a Therapeutic Target. [Abstract]

2026 May 13;26(5):48. PMID: 42126728
Food Chem Toxicol

Mechanisms of LPS-induced toxicity in endothelial cells and the protective role of geniposidic acid. [Abstract]

2025 Apr 25:115488. PMID: 40288513
Am J Transl Res

ZLN005 protects against ischemia-reperfusion-induced kidney injury by mitigating oxidative stress through the restoration of mitochondrial fatty acid oxidation. [Abstract]

2021 Sep 15;13(9):10014-10037. PMID: 34650679
medRxiv

2025 Oct 13.
bioRxiv

2025 Oct 22.
SSRN

2024 Apr 17.
Research Square Preprint

2021 Nov.
Research Square Preprint

2021 Jul.
Aging

PGC-1α alleviates mitochondrial dysfunction via TFEB-mediated autophagy in cisplatin-induced acute kidney injury. [Abstract]

2021 Mar 10;13(6):8421-8439. PMID: 33714196
Oxid Med Cell Longev

The Nrf2/PGC1 α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer. [Abstract]

2020 Nov 26;2020:4830418. PMID: 33294122
Aging (Albany NY)

PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells. [Abstract]

2020 Apr 28;12(8):7411-7430. PMID: 32343674
Evid Based Complement Alternat Med

The Essential Oil from Acori Tatarinowii Rhizome (the Dried Rhizome of Acorus tatarinowii Schott) Prevents Hydrogen Peroxide-Induced Cell Injury in PC12 Cells: A Signaling Triggered by CREB/PGC-1 α Activation. [Abstract]

2020 Mar 9;2020:4845028. PMID: 32215040

Solvente y solubilidad

In Vitro:

DMSO : 12.5 mg/mL (49.93 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : 5 mg/mL (19.97 mM; Need ultrasonic)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.9946 mL

19.9728 mL

39.9457 mL

5 mM

0.7989 mL

3.9946 mL

7.9891 mL

10 mM

0.3995 mL

1.9973 mL

3.9946 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Calculadora de molaridad

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculadora de dilución

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: 2.2 mg/mL (8.79 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.2 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (22.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 1.25 mg/mL (4.99 mM); Clear solution

This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 1.25 mg/mL (4.99 mM); Clear solution

This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL Corn oil, and mix evenly.

Working Solution

For the following dissolution methods, please prepare the working solution directly:

It is recommended to prepare fresh solutions and use them promptly within a short period of time.

The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 50% PEG300 50% Saline

Solubility: 1.67 mg/mL (6.67 mM); Suspended solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Pureza y Documentación

Select Batch:

Pureza: 99.98%

Assay: 99.98%

ee.: 99.98%

Ficha de datos (273 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instrucciones de manejo (2659 KB)

Referencias

[1]. Zhang LN, et al. Novel small-molecule PGC-1α transcriptional regulator with beneficial effects on diabetic db/db mice. Diabetes. 2013 Apr;62(4):1297-307. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
Ethanol / DMSO	1 mM	3.9946 mL	19.9728 mL	39.9457 mL	99.8642 mL
	5 mM	0.7989 mL	3.9946 mL	7.9891 mL	19.9728 mL
	10 mM	0.3995 mL	1.9973 mL	3.9946 mL	9.9864 mL
	15 mM	0.2663 mL	1.3315 mL	2.6630 mL	6.6576 mL
DMSO	20 mM	0.1997 mL	0.9986 mL	1.9973 mL	4.9932 mL
	25 mM	0.1598 mL	0.7989 mL	1.5978 mL	3.9946 mL
	30 mM	0.1332 mL	0.6658 mL	1.3315 mL	3.3288 mL
	40 mM	0.0999 mL	0.4993 mL	0.9986 mL	2.4966 mL

Keywords

ZLN005

51 Cited Publications

100 mg Obtener un presupuesto

Subscribe to the

MedChemExpress

Newsletter

Nombre del producto:
Referencia número:
Cantidad:
MCE Japan Authorized Agent:

Nombre del producto:
No. CAS:
Species:
Pureza:
Cantidad:

ZLN005

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-diabetic Compound Library

Neuroprotective Compound Library

Anti-Parkinson's Disease Compound Library

Neurodegenerative Disease-related Compound Library

Lipid Metabolism Compound Library

Glucose Metabolism Compound Library

Targeted Diversity Library

Mitochondrial Protection Compound Library

Metabolic Enzyme Compound Library

Mitochondrial Toxicity Compound Library

Cell Death Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Lactic Acid Metabolic Compound Library

High-Throughput Bioactive Compound Library

MCE Kinase Hinge Binder Fragment Library

Publications Citing Use of MedChemExpress (MCE) ZLN005

Actividad biológica

Chemical Information

Publications (51)

Solvente y solubilidad

Pureza y Documentación

Referencias

Help & FAQs

Complete Stock Solution Preparation Table

ZLN005

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-diabetic Compound Library

Neuroprotective Compound Library

Anti-Parkinson's Disease Compound Library

Neurodegenerative Disease-related Compound Library

Lipid Metabolism Compound Library

Glucose Metabolism Compound Library

Targeted Diversity Library

Mitochondrial Protection Compound Library

Metabolic Enzyme Compound Library

Mitochondrial Toxicity Compound Library

Cell Death Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Lactic Acid Metabolic Compound Library

High-Throughput Bioactive Compound Library

MCE Kinase Hinge Binder Fragment Library

Publications Citing Use of MedChemExpress (MCE) ZLN005

Actividad biológica

Chemical Information

Publications (51)

Solvente y solubilidad

Pureza y Documentación

Referencias

Help & FAQs

Complete Stock Solution Preparation Table

ZLN005 Related Classifications

HY-17538 Related Classifications